ACAP2
Arf-GAP with coiled-coil, ANK repeat and PH domain-containing protein 2
Also known as: ACAP2_HUMAN, CENTB2, CNT-B2, KIAA0041
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q15057
- Gene
- ACAP2
- Ensembl
- ENSG00000114331
- Chromosome
- 3
- Canonical length
- 778 aa
- Protein class
- Plasma proteins, Predicted intracellular proteins
- Subcellular location
- Endosomes
OverviewNCBI Gene
Enables GTPase activator activity. Acts upstream of or within actin filament-based process. Located in ruffle. [provided by Alliance of Genome Resources, Apr 2025]
Canonical amino-acid sequenceUniProt
778 residues, UniProt reviewed canonical sequence.
>Q15057|ACAP2
1 MKMTVDFEEC LKDSPRFRAA LEEVEGDVAE LELKLDKLVK LCIAMIDTGK AFCVANKQFM
61 NGIRDLAQYS SNDAVVETSL TKFSDSLQEM INFHTILFDQ TQRSIKAQLQ NFVKEDLRKF
121 KDAKKQFEKV SEEKENALVK NAQVQRNKQH EVEEATNILT ATRKCFRHIA LDYVLQINVL
181 QSKRRSEILK SMLSFMYAHL AFFHQGYDLF SELGPYMKDL GAQLDRLVVD AAKEKREMEQ
241 KHSTIQQKDF SSDDSKLEYN VDAANGIVME GYLFKRASNA FKTWNRRWFS IQNNQLVYQK
301 KFKDNPTVVV EDLRLCTVKH CEDIERRFCF EVVSPTKSCM LQADSEKLRQ AWIKAVQTSI
361 ATAYREKGDE SEKLDKKSSP STGSLDSGNE SKEKLLKGES ALQRVQCIPG NASCCDCGLA
421 DPRWASINLG ITLCIECSGI HRSLGVHFSK VRSLTLDTWE PELLKLMCEL GNDVINRVYE
481 ANVEKMGIKK PQPGQRQEKE AYIRAKYVER KFVDKYSISL SPPEQQKKFV SKSSEEKRLS
541 ISKFGPGDQV RASAQSSVRS NDSGIQQSSD DGRESLPSTV SANSLYEPEG ERQDSSMFLD
601 SKHLNPGLQL YRASYEKNLP KMAEALAHGA DVNWANSEEN KATPLIQAVL GGSLVTCEFL
661 LQNGANVNQR DVQGRGPLHH ATVLGHTGQV CLFLKRGANQ HATDEEGKDP LSIAVEAANA
721 DIVTLLRLAR MNEEMRESEG LYGQPGDETY QDIFRDFSQM ASNNPEKLNR FQQDSQKFLocalizationUniProt · AlphaFold · HPA
Whether an antibody against ACAP2 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.36
- Highest tissue expression
- 33 nTPM
Expression across tissuesHPA
Tissue
- bone marrow: 33 nTPM
- tonsil: 25 nTPM
- lymph node: 23 nTPM
- spleen: 22 nTPM
- retina: 22 nTPM
- appendix: 20 nTPM
Single-cell type
- neutrophils: 2,226 nCPM
- neutrophil progenitors: 1,126 nCPM
- esophageal apical cells: 609 nCPM
- pituicytes/fscs: 548 nCPM
- retinal horizontal cells: 543 nCPM
- monocytes: 467 nCPM
Immune cell
- neutrophil: 227 nTPM
- basophil: 66 nTPM
- non-classical monocyte: 63 nTPM
- eosinophil: 59 nTPM
- classical monocyte: 58 nTPM
- intermediate monocyte: 51 nTPM
Brain region
- cerebellum: 55 nTPM
- hippocampal formation: 46 nTPM
- cerebral cortex: 45 nTPM
- basal ganglia: 43 nTPM
- amygdala: 43 nTPM
- hypothalamus: 42 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.32
- gnomAD pLI
- 0.92
- gnomAD missense Z
- 3.22
- DepMap mean gene effect
- -0.04
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 13% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Arf GTPase activating protein
- Pleckstrin homology domain
- Ankyrin repeat
- BAR domain
- PH-like domain superfamily
- AH/BAR domain superfamily
- Ankyrin repeat-containing domain superfamily
- ARFGAP/RecO-like zinc finger
- ArfGAP domain superfamily
- ArfGAP ACAP1/2/3-like
- PH domain
- Putative GTPase activating protein for Arf
- Ankyrin repeats (3 copies)
- BAR domain of APPL family
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of ACAP2 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads ACAP2 as an antibody target. Whether an autoantibody or antibody against ACAP2 could matter depends on whether native ACAP2 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
ACAP2 is annotated at the cell surface, where native ACAP2 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label ACAP2 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...